Capital Signal

Vitrafy Life Sciences Limited (ASX: VFY)

Sector: Health Care

Market cap: A$173M (as of 2 Nov 2026)

The main business activity of Vitrafy is the product development and commercialisation of its vertically integrated cryopreservation solution.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
8 July 2026SPP$2M$2.60—Filing ↗
22 Nov 2024Public offer$34.96M$1.84—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
19 Jan 2026Ryder Investment Management Pty Ltd and related entities and persons listed in section 4Increase6.460% → 7.560%Filing ↗
5 Aug 2025RYDER CAPITAL LIMITED & ASSOCIATED ENTITIESEntry?% → 6.4%Filing ↗
26 Nov 2024Ryder Capital Limted and associated entitiesEntry?% → 6.460%Filing ↗
22 Nov 2024STACEY INV AUST PTY LTDEntry?% → 5.07%Filing ↗

Director trades — on-market

DateDirectorTradeSource
19 Feb 2026Leigh FARRELLBought 15,311Filing ↗
29 Aug 2025Dr John McBainBought 37,000Filing ↗
18 Mar 2025Dr John McBainBought 28,255Filing ↗
10 Dec 2024Dr John McBainBought 27,500 sharesFiling ↗

Ask about VFY in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has VFY raised money in the last year, and at what discount?
  • What was VFY's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading VFY…